' Reassuring Data ' for Two Multiple Sclerosis Meds in Pregnancy ' Reassuring Data ' for Two Multiple Sclerosis Meds in Pregnancy

Two studies report few complications from continuing ocrelizumab and natalizumab into pregnancy, with high live birth rates, a decline in elective abortions, and few major congenital abnormalities in newborns.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news